D-1407-2019 Class II Terminated

Recalled by P & L Developments, LLC — Westbury, NY

FDA drug recall D-1407-2019 was initiated by P & L Developments, LLC on Jun 5, 2019 and is designated Class II. Reason for recall: cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with… The recall status is terminated (terminated Sep 9, 2020). Affected quantity: 202,068 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 26, 2019
Initiation Date
Jun 5, 2019
Termination Date
Sep 9, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
202,068 bottles

Product description

Cetirizine HCL Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Gluten Free, Grape Flavor, 5 mg/5mL, 4 FL. oz. Bottle, Distributed by Dolgencorp, LLC, 100 mission ridge, Goodlettsville, TN 37072, NDC 55910-878-04, UPC 359726178051.

Reason for recall

cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Distribution pattern

Nationwide in the U.S.

Code information

Lot #s: C00138; A48440, Exp. 5/19; C02434; C04186, Exp. 6/19; C07864, Exp. 7/19; F13277; C08962; F13778, Exp. 10/19; C11746; F05899; F13777, Exp. 12/19; F09356; F10784; F13595, Exp. 2/20; F22355; F23239, Exp. 8/20.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1407-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1407-2019. Report a data issue: hello@regdatalab.com.